Body dysmorphic disorder: Diagnostic controversies and treatment challenges

Bulletin of the Menninger Clinic

Volumn 64, Issue 1, 2000, Pages 18-35

  Phillips, Katharine ^a,b  

^a BUTLER HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

AGORAPHOBIA; BEHAVIOR THERAPY; BODY DYSMORPHIC DISORDER; CONFERENCE PAPER; DELUSION; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; OBSESSION; PANIC; SCHIZOPHRENIA; SOCIAL PHOBIA; TREATMENT OUTCOME; TREATMENT PLANNING; TRICHOTILLOMANIA;

ADULT; AGE FACTORS; ANTIPSYCHOTIC AGENTS; CHILD; COGNITIVE THERAPY; DELUSIONS; DEPRESSION; DIAGNOSIS, DIFFERENTIAL; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS; SOMATOFORM DISORDERS;

EID: 0033962430     PISSN: 00259284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (57)

1. Albertini, R. S., & Phillips, K. A. (1999). Thirty-three cases of body dysmorphic disorder in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 453-459.
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed). Washington, DC: Author.
3. Andreasen, N. C., & Bardach, J. (1977). Dysmorphophobia: Symptom or disease? American Journal of Psychiatry, 134, 673-675.
4. Brady, K. T., Austin, L., & Lydiard, R. B. (1990). Body dysmorphic disorder: The relationship to obsessive-compulsive disorder. Journal of Nervous and Mental Disease, 175, 538-540.
5. Brawman-Mintzer, O., Lydiard, R. B., Phillips, K. A., Morton, A., Czepowicz, V., Emmanuel, N., Villareal, G., Johnson, M., & Ballenger, J. C. (1995). Body dysmorphic disorder in patients with anxiety disorders and major depression: A comorbidity study. American Journal of Psychiatry, 152, 1665-1667.
6. Carroll, B. J. (1994). Response of major depression with psychosis and body dysmorphic disorder to ECT [letter to the editor]). American Journal of Psychiatry, 151, 288-289.
7. Deckersbach, T., Savage, C. R., Phillips, K. A., Wilhelm, S., Buhlman, U., Rauch, S. L., Baer, L., & Jenike, M. A. (1998). Characteristics of memory dysfunction in body dysmorphic disorder. Paper presented at the Scientific Abstracts, American College of Neuropsychopharmacology 34th Annual Meeting. Las Croabas, Puerto Rico.
8. DeMarco, L. M., Li, L. C., Phillips, K. A., & McElroy, S. L. (1998). Perceived stress in body dysmorphic disorder. Journal of Nervous and Mental Disease, 186, 724-726.
9. Eisen, J. L., Phillips, K. A., Beer, L., Beer, D. A., Atala, K. D., & Rasmussen, S. A. (1998). The Brown Assessment of Beliefs Scale: Reliability and validity. American Journal of Psychiatry, 155, 102-108.
10. Eisen, J. L., Phillips, K. A., Rasmussen, S. A., & Luce, D. (1997, May). Insight in body dysmorphic disorder versus OCD. Paper presented at the New Research Program and Abstracts, American Psychiatric Association 150th Annual Meeting, San Diego.
11. Foa, E. B. (1979). Failure in treating obsessive-compulsives. Behavioral Research Therapy, 17, 169-176.
12. Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Delgado, P., Heninger, G. R., & Charney, D. S. (1989a). The Yale-Brown Obsessive Compulsive Scale (Y-BOCS): Part II. Validity. Archives of General Psychiatry, 46, 1012-1016.
13. Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischman, R. L., Hill, C. L., Heninger, G. R., & Charney, D. S. (1989b). The Yale-Brown Obsessive Compulsive Scale (Y-BOCS): Part I. Development, use, and reliability. Archives of General Psychiatry, 46, 1006-1011.
14. Hanes, K. R. (1998). Neuropsychological performance in body dysmorphic disorder. Journal of the International Neuropsychological Society, 4, 167-171.
15. Hay, G. G. (1970). Dysmorphophobia. British Journal of Psychiatry, 116, 399-406.
16. Hollander, E. (1993). Introduction. In E. Hollander (Ed.), Obsessive-compulsive related disorders. Washington, DC: American Psychiatric Press.
17. Hollander, E., Allen, A., Aronowitz, B., Kwon, J., Mosovich, S., Schmeidler, J., & Wong, C. (in press). Clomipramine/desipramine crossover trial in body dysmorphic disorder: Selective efficacy of serotonin reuptake inhibitors in an obsessive compulsive spectrum disorder. Archives of General Psychiatry.
18. Hollander, E., Cohen, L. J., & Simeon, D. (1993). Body dysmorphic disorder. Psychiatric Annals, 23, 359-364.
19. Hollander, E., Cohen, L., Simeon, D., Rosen, J., DeCaria, C., & Stein, D. J. (1994). Fluvoxamine treatment of body dysmorphic disorder [letter to the editor]. Journal of Clinical Psychopharmacology, 14, 75-77.
20. Hollander, E., Liebowitz, M. R., Winchel, R., Klumker, A., & Klein, D. F. (1989). Treatment of body-dysmorphic disorder with serotonin reuptake blockers. American Journal of Psychiatry, 146, 768-770.
21. Hollander, E., & Phillips, K. A. (1993). Body image and experience disorders: Body dysmorphic and depersonalization disorders. In E. Hollander (Ed), Obsessive compulsive-related disorders (pp. 17-48). Washington, DC: American Psychiatric Press.
22. Janet, P. (1903). Les obsessions et la psychasthenie. Paris: Felix Alcan.
23. Koran, L. M., Thienemann, M. L., & Davenport, R. (1996). Quality of life for patients with obsessive-compulsive disorder. American Journal of Psychiatry, 153, 783-788.
24. Marks, I., & Mishan, J. (1988). Dysmorphophobic avoidance with disturbed bodily perception: A pilot study of exposure therapy. British Journal of Psychiatry, 152, 674-678.
25. McElroy, S. L., Phillips, K. A., & Keck, P. E., Jr. (1994). Obsessive-compulsive spectrum disorders. Journal of Clinical Psychiatry, 55(Suppl.), 33-51.
26. McKay, D., Todaro, J., Neziroglu, F., Campisi, T., Morizt, E. K., & Yaryura-Tobias, J. A. (1997). Body dysmorphic disorder: A preliminary evaluation of treatment and maintenance using exposure with response prevention. Behaviour Research and Therapy, 35, 67-70.
27. Morselli, E. (1891). Sulla dismorfofobia e sulla tafefobia. Bolletinno della R accademia di Genova, 6, 110-119.
28. Munro, A., & Chmara, J. (1982). Monosymptomatic hypochondriacal psychosis: A diagnostic checklist based on 50 cases of the disorder. Canadian Journal of Psychiatry, 27, 374-376.
29. Neziroglu, F. A., & Yaryura-Tobias, J. A. (1993). Exposure, response prevention, and cognitive therapy in the treatment of body dysmorphic disorder. Behavior Therapy, 24, 431-438.
30. Nierenberg, A. A., Phillips, K. A., Kaji, J., Alpert, J. E., Worthington, J. J., & Fava, M. (1995, May). Body dysmorphic disorder is comorbid with major depression. Paper presented at the New Research Program and Abstracts, American Psychiatric Association 148th Annual Meeting, Miami.
31. Opler, L. A., & Feinberg, S. S. (1991). The role of pimozide in clinical psychiatry: A review. Journal of Clinical Psychiatry, 52, 221-233.
32. Perugi, G., Akiskal, H. S., Lattanzi, L., Cecconi, D., Mastrocinque, C., Patronelli, A., Vignoli, S., & Berni, E. (1998). The high prevalence of "soft" bipolar (II) features in atypical depression. Comprehensive Psychiatry, 39, 63-71.
33. Perugi, G., Giannotti, D., Di Vaio, S., Frare, F., Saettoni, M., & Cassano, G. B. (1996). Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). International Clinical Psychopharmacology, 11, 247-254.
34. Perugi, G., Giannotti, D., Frare, F., Di Vaio, S., Valori, E., Maggi, L., Cassano, G. B., & Akiskal, H. S. (1997). Prevalence, phenomenology, and comorbidity of body dysmorphic disorder (dysmorphophobia) in a clinical population. International Journal of Psychiatry in Clinical Practice, 1, 77-82.
35. Phillips, K. A. (1991). Body dysmorphic disorder: The distress of imagined ugliness. American Journal of Psychiatry, 148, 1138-1149.
36. Phillips, K. A (1996a). The broken mirror: Understanding and treating body dysmorphic disorder. New York: Oxford University Press.
37. Phillips, K. A. (1996b). An open study of buspirone augmentation of serotonin-reuptake inhibitors in body dysmorphic disorder. Psychopharmacology Bulletin, 32, 175-180.
38. Phillips, K. A. (in press). Quality of life in body dysmorphic disorder. Journal of Nervous and Mental Disease.
39. Phillips, K. A., Atala, K. D., & Albertini, R. S. (1995). Body dysmorphic disorder in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1216-1220.
40. Phillips, K. A., & Diaz, S. (1997). Gender differences in body dysmorphic disorder. Journal of Nervous and Mental Disease 185, 570-577.
41. Phillips, K. A., Dwight, M. M., & McElroy, S. L. (1998). Efficacy and safety of fluvoxamine in body dysmorphic disorder. Journal of Clinical Psychiatry, 59, 165-171.
42. Phillips, K. A., Gunderson, C. G., Mallya, G., McElroy, S. L., & Carter, W. (1998). A comparison study of body dysmorphic disorder and obsessive compulsive disorder. Journal of Clinical Psychiatry, 59, 568-575.
43. Phillips, K. A., & Hollander, E. (1996). Body dysmorphic disorder. In T. A. Widiger, A. J. Frances, H. A. Pincus, R. Ross, M. B. First, & W. W. Davis (Eds.), DSM-IV sourcebook (Vol 2, pp. 949-960). Washington, DC: American Psychiatric Association.
44. Phillips, K. A., & McElroy, S. L. (1993). Insight, overvalued ideation, and delusional thinking in body dysmorphic disorder: Theoretical and treatment implications. Journal of Nervous and Mental Disease, 181, 699-702.
45. Phillips, K. A., McElroy, S. L., Hudson, J. I., & Pope, H. G. (1995). Body dysmorphic disorder: An obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both? Journal of Clinical Psychiatry, 56 (Suppl.), 41-51.
46. Phillips, K. A., McElroy, S. L., Keck, P. E., Jr., Pope, H. G., Jr., & Hudson, J. I. (1993). Body dysmorphic disorder: 30 cases of imagined ugliness. American Journal of Psychiatry, 150, 302-308.
47. Phillips, K. A., McElroy, S. L., Keck, P. E., Jr., Pope, H. G., Jr., & Hudson, J. I. (1994). A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacology Bulletin, 30, 179-186.
48. Phillips, K. A., Nierenberg, A. A., Brendel, G., & Fava, M. (1996). Prevalence and clinical features of body dysmorphic disorder in atypical major depression. Journal of Nervous and Mental Disease, 184, 125-129.
49. Phillips, K. A., Van Noppen, B., & Shapiro, L. (1997). Learning to live with body dysmorphic disorder. Milford, CT: Obsessive-Compulsive Foundation.
50. Rosen, J. C., & Ramirez, E. (1998). A comparison of eating disorders and body dysmorphic disorder on body image and psychological adjustment. Journal of Psychosomatic Research 44, 441-449.
51. Rosen, J. C., Reiter, J., & Orosan, P. (1995). Cognitive-behavioral body image therapy for body dysmorphic disorder. Journal of Consulting and Clinical Psychology, 63, 263-269.
52. Simeon, D., Hollander, E., Stein, D. J., Cohen, L., & Aronowitz, B. (1995). Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. American Journal of Psychiatry, 152, 1207-1209.
53. Sondheimer, A. (1988). Clomipramine treatment of delusional disorder, somatic type. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 188-192.
54. Veale, D., Boocock, A., Gournay, K., Dryden, W., Shah, F., Willson, R., & Walburn, J. (1996). Body dysmorphic disorder: A survey of fifty cases. British Journal of Psychiatry, 169, 196-201.
55. Veale, D., Gournay, K., Dryden, W., Boocock, A., Shah, F., Willson, R., & Walburn, J. (1996). Body dysmorphic disorder: A cognitive behavioural model and pilot randomized controlled trial. Behavior Research and Therapeutics, 34, 717-729.
56. Wilhelm, S., Otto, M. W., Lohr, B., & Deckersback, T. (1999). Cognitive behavior group therapy for body dysmorphic disorder: A case series. Behaviour Research and Therapy, 37, 71-75.
57. Zimmerman, M., & Mattia, J. I. (1998). Body dysmorphic disorder in psychiatric outpatients: Recognition, prevalence, comorbidity, demographic, and clinical correlates. Comprehensive Psychiatry, 39, 265-270.